FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

TORONTO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company ...

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.

MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...

Mounjaro is FDA-approved for type 2 diabetes. [4] Compounded tirzepatide: Medication produced by compounded pharmacies ...

Understanding the right dose of Ozempic for you can feel a bit confusing, especially if you’re just getting started. While ...

Obe-cel is the first FDA-approved CAR T-cell therapy for B-ALL without a REMS ... we believe are critical for long term ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...

Brands marketing foods and ingredients for mood management must navigate a complex regulatory landscape by understanding ...